Affiliation:
1. IBEX Pharmaceuticals Inc., Montreal, Quebec H4P 1P7, Canada
Abstract
ABSTRACT
A system for high-level expression of heparinase I, heparinase II, heparinase III, chondroitinase AC, and chondroitinase B in
Flavobacterium heparinum
is described.
hepA
, along with its regulatory region, as well as
hepB
,
hepC
,
cslA
, and
cslB
, cloned downstream of the
hepA
regulatory region, was integrated in the chromosome to yield stable transconjugant strains. The level of heparinase I and II expression from the transconjugant strains was approximately fivefold higher, while heparinase III expression was 10-fold higher than in wild-type
F. heparinum
grown in heparin-only medium. The chondroitinase AC and B transconjugant strains, grown in heparin-only medium, yielded 20- and 13-fold increases, respectively, in chondroitinase AC and B expression, compared to wild-type
F. heparinum
grown in chondroitin sulfate A-only medium. The
hepA
upstream region was also studied using
cslA
as a reporter gene, and the transcriptional start site was determined to be 26 bp upstream of the start codon in the chondroitinase AC transconjugant strain. The transcriptional start sites were determined for
hepA
in both the wild-type
F. heparinum
and heparinase I transconjugant strains and were shown to be the same as in the chondroitinase AC transconjugant strain. The five GAG lyases were purified from these transconjugant strains and shown to be identical to their wild-type counterparts.
Publisher
American Society for Microbiology
Subject
Molecular Biology,Microbiology
Reference40 articles.
1. Baug, R. F., and J. J. Zimmermann. 1993. Heparinase in the activated clotting time assay: monitoring heparin-independent alternations in coagulation function. Perfusion Rev.1:14-28.
2. Boorstein, W. R., and E. A. Craig. 1989. Primer extension analysis from RNA. Methods Enzymol.180:347-369.
3. Christensen, P. 1980. Description and taxonomic status of Cytophaga heparina (Payza and Korn) comb. nov. (basionym: Flavobacterium heparinum Payza and Korn 1956). Int. J. Syst. Bacteriol.30:473-475.
4. Denholm, E. M., E. Cauchon, C. Poulin, and P. J. Silver. 2000. Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur. J. Pharmacol.400:145-153.
5. Ernst, S., O. A. Garro, S. Winkler, G. Venkataraman, R. Langer, C. L. Cooney, and R. Sasisekharan. 1997. Process simulation for recombinant protein production: cost estimation and sensitivity analysis for heparinase I expressed in Escherichia coli. Biotechnol. Bioeng.53:575-582.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献